Obesity and outcomes in premenopausal and postmenopausal breast cancer.
about
The Obesity-Breast Cancer Conundrum: An Analysis of the IssuesRisk factors and biomarkers of life-threatening cancersCross-Talk between Adiponectin and IGF-IR in Breast CancerA lesson for cancer research: placental microarray gene analysis in preeclampsiaObesity in cancer survivalBody mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studiesThe impact of overweight and obesity on breast cancer: data from Switzerland, so far a country little affected by the current global obesity epidemicExemestane for breast cancer prevention: a critical shift?Body Mass Index with Tumor 18F-FDG Uptake Improves Risk Stratification in Patients with Breast CancerAssociations between metabolic syndrome, breast cancer recurrence, and the 21-gene recurrence score assayBreast cancer and obesity: in vitro interferences between adipokines and proangiogenic features and/or antitumor therapies?Weight change during chemotherapy changes the prognosis in non metastatic breast cancer for the worse.Endocrine therapy in obese patients with primary breast cancer: another piece of evidence in an unfinished puzzle.Survival analysis of 1148 women diagnosed with breast cancer in Southern Iran.Monocyte chemotactic protein-1 deficiency attenuates and high-fat diet exacerbates bone loss in mice with Lewis lung carcinomaLeptin signals via TGFB1 to promote metastatic potential and stemness in breast cancer.Plasma homocysteine and cysteine and risk of breast cancer in women.Obesity and Prognostic Variables in Colombian Breast Cancer Patients: A Cross-Sectional Study.Combination of physical activity, nutrition, or other metabolic factors and vaccine responseWeight changes and lifestyle behaviors in women after breast cancer diagnosis: a cross-sectional studyPast recreational physical activity, body size, and all-cause mortality following breast cancer diagnosis: results from the Breast Cancer Family Registry.Pre-diagnosis body mass index, post-diagnosis weight change, and prognosis among women with early stage breast cancerBody mass index and survival after breast cancer diagnosis in Japanese women.Given breast cancer, does breast size matter? Data from a prospective breast cancer cohort.Energy balance, host-related factors, and cancer progression.Obesity or overweight is associated with worse pathological response to neoadjuvant chemotherapy among Chinese women with breast cancerClinical and genetic predictors of weight gain in patients diagnosed with breast cancer.Effects of a high-fat diet on spontaneous metastasis of Lewis lung carcinoma in plasminogen activator inhibitor-1 deficient and wild-type mice.Effect of body mass index on breast cancer during premenopausal and postmenopausal periods: a meta-analysis.Association of Body Mass Index Changes during Neoadjuvant Chemotherapy with Pathologic Complete Response and Clinical Outcomes in Patients with Locally Advanced Breast CancerBody mass index is associated with gene methylation in estrogen receptor-positive breast tumors.Obesity and survival among black women and white women 35 to 64 years of age at diagnosis with invasive breast cancerResistin, visfatin, adiponectin, and leptin: risk of breast cancer in pre- and postmenopausal saudi females and their possible diagnostic and predictive implications as novel biomarkers.Effect of obesity on outcomes after autologous hematopoietic stem cell transplantation for multiple myeloma.Leptin deficiency suppresses MMTV-Wnt-1 mammary tumor growth in obese mice and abrogates tumor initiating cell survival.Weight change and its correlates among breast cancer survivors.Impact of weight change during neoadjuvant chemotherapy on pathologic response in triple-negative breast cancerThe Possible Impact of Obesity on Androgen, Progesterone and Estrogen Receptors (ERα and ERβ) Gene Expression in Breast Cancer Patients.The effect of overweight and nutrition on prognosis in breast cancer.Obesity is an independent predictor of poor survival in metastatic breast cancer: retrospective analysis of a patient cohort whose treatment included high-dose chemotherapy and autologous stem cell support.
P2860
Q26747486-5153053F-906F-4730-8091-79F87C5CD17CQ26774591-358031ED-3A46-4D35-9A1A-753DB4D9B9DEQ26799865-0A65A0D7-6311-4E1B-9124-45A861A73455Q26827543-2EB247A9-1A8B-4897-B5F3-DFBE663F2267Q26863606-A8EC61BB-1B95-4BAB-B651-EFB6E2100917Q27014939-D88CFF75-E483-4283-BC22-B61E88387438Q27021293-FC9C551B-2420-4A6A-9846-3E884B86A502Q27028211-D168D8C8-3C6D-4377-B029-AA0B2D06F4FAQ28109681-7E3BA78D-F2DA-4EBC-8458-1CF09CCFCDAEQ28393247-A7C08D8F-A858-46DA-B998-69DC1B72F38DQ28488129-6310603F-F609-4310-8E0A-D84E859B2F1BQ30992559-B7EB7C75-DD6C-4A86-8F22-0EE2817882F4Q33352521-8D2ED5D6-804C-43F7-A2F1-29086092B2F4Q33460752-2480FCF7-1D20-4094-9D62-1F0DBAFA54FCQ33618672-AF0A68E1-2B7A-4F30-B500-52A037CAC08EQ33728621-14D6079A-B9BC-4DF5-A8A0-857CD8FF7B96Q33733182-090C3D57-A94B-4152-86FC-DFE10BD5B7E8Q33747941-940E6850-A5BA-48EF-B0B1-7FC5B67BC9BDQ33751144-798ED2FC-F8DE-497C-8155-F174B74107FBQ33898993-D80F1351-29F7-4654-A864-8E8DC08D2AD9Q34061135-3DBD39CB-7955-4153-ADCB-DBC63BF87CA6Q34078823-2F3F3E93-403F-43CE-B903-83A558570C6BQ34236103-F1FE7717-0FB7-4D69-84D3-1D055CAFD402Q34303594-A0583705-FCD7-4693-A392-DF3B652C5E26Q34315762-20E06A5B-CA7A-4EF0-8E15-63EA9CC1E9CAQ34358393-87E75633-6C62-4238-B9BE-F89208DA9A53Q34362327-816160CD-B435-49DE-9A91-53627817BDACQ34428870-A0548FBC-7EAA-4A1F-868F-7FDA2101FF3EQ34511016-39FF1BEC-E634-42E5-9596-8090C28F7649Q35148075-42EF70C5-505A-4FE9-93E0-8D4D461B5E75Q35163988-6D9B808D-8667-4870-BB74-0C65F68FBBA0Q35187810-48972899-C2D8-4A18-8E01-8C72C1F5830EQ35206787-847BB355-BE76-474A-8C15-0AC8B542DCDFQ35219011-C5228F77-7754-4FC4-88FF-0DFE7ACBD30DQ35399575-49A4307A-0549-4C39-AE9B-282C446E8B6FQ35414353-D831B08F-BD2B-48FF-A8B0-18E584A16EEDQ35469275-41E04932-EE8A-469A-AEDA-31C7CD94B360Q35607776-E8901385-DD73-461F-A5CB-BF864FEEFB25Q35619132-0EFA8CA5-0D04-43DD-BE92-F840BA1AE76AQ35684496-B0323461-C926-4976-87A2-41558171EEEE
P2860
Obesity and outcomes in premenopausal and postmenopausal breast cancer.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Obesity and outcomes in premenopausal and postmenopausal breast cancer.
@en
Obesity and outcomes in premenopausal and postmenopausal breast cancer.
@nl
type
label
Obesity and outcomes in premenopausal and postmenopausal breast cancer.
@en
Obesity and outcomes in premenopausal and postmenopausal breast cancer.
@nl
prefLabel
Obesity and outcomes in premenopausal and postmenopausal breast cancer.
@en
Obesity and outcomes in premenopausal and postmenopausal breast cancer.
@nl
P50
P1476
Obesity and outcomes in premenopausal and postmenopausal breast cancer.
@en
P2093
Margaret R E McCredie
Michael L Friedlander
P304
P356
10.1158/1055-9965.EPI-05-0042
P577
2005-07-01T00:00:00Z